Pathological role of excessive DNA as a trigger of keratinocyte proliferation in psoriasis
Psoriasis is characterized by excessive growth and aberrant differentiation of epidermal keratinocytes due to persistent inflammation. However, the underlying mechanism that triggers immune activation in psoriasis is not clear. In this study, we explored excessive DNA as a potential trigger of psoriasis using cultured human keratinocytes and psoriatic skin tissues. We demonstrated that human genomic DNA fragments induced tumour necrosis factor (TNF)‐α expression, hyperproliferation and over‐expression of heparin‐binding epidermal‐like growth factor (HB‐EGF) and transforming growth factor (TGF)‐α, accompanied by defective expression of keratins 1 and 10 in cultured normal human epidermal keratinocytes, which have a similar phenotype to that of keratinocytes in psoriatic skin lesions. In psoriatic lesions, we found high levels of double‐stranded (ds)DNA fragments, accompanying keratinocytes expressing Ki‐67, HB‐EGF and TNF‐α. In addition, we showed that 1,25‐dihydroxyvitamin D3 inhibited genomic DNA fragment‐induced TNFA and interleukin‐1β (IFNB) expression in human keratinocytes, and an intact function of cathelicidin anti‐microbial peptide (CAMP) was required for this effect. These results suggest that excessive dsDNA fragments probably act as a risk factor for immune activation in psoriasis, and the active form of vitamin D can prevent genomic DNA‐mediated skin inflammation via CAMP.